Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cylite pty ltd - 58860 - multi-purpose digital medical camera external ophthalmoscopic lens - these non-sterile, non-contact, optical lenses are used in conjunction with cylite hp-oct instruments to assist in acquiring optical imaging of the anterior segment of the eye. these are reusable devices.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

cylite pty ltd - 58861 - multi-purpose digital medical camera ophthalmoscopic lens - these non-sterile, non-contact, optical lenses are used in conjunction with cylite hp-oct instruments to assist in acquiring optical imaging of the posterior segment of the eye. these are reusable devices.

Malta - inglise - Medicines Authority

ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - cromoglicate sodium - eye drops, solution - cromoglicate sodium 20 mg/ml - ophthalmologicals

Malta - inglise - Medicines Authority

ursapharm arzeneitmittel gmbh industriestrasse, 66129 saarbrucken, germany - antazoline phosphate, tetryzoline hydrochloride - eye drops, solution - antazoline phosphate 0.15 mg/ml tetryzoline hydrochloride 0.5 mg/ml - ophthalmologicals

Euroopa Liit - inglise - EMA (European Medicines Agency)

santen oy - ciclosporin - corneal diseases - ophthalmologicals - treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.

Euroopa Liit - inglise - EMA (European Medicines Agency)

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - ophthalmologicals - lucentis is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to choroidal neovascularisation (cnv)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)

Euroopa Liit - inglise - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - ophthalmologicals - macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration (amd).

Euroopa Liit - inglise - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - ophthalmologicals - visudyne is indicated for the treatment of:adults with exudative (wet) age-related macular degeneration (amd) with predominantly classic subfoveal choroidal neovascularisation (cnv) or;adults with subfoveal choroidal neovascularisation secondary to pathological myopia.

Malta - inglise - Medicines Authority

novartis pharmaceuticals uk limited - moxifloxacin - eye drops, solution - moxifloxacin 5 mg/ml - ophthalmologicals

Euroopa Liit - inglise - EMA (European Medicines Agency)

santen oy - ciclosporin - conjunctivitis; keratitis - ophthalmologicals - treatment of severe vernal keratoconjunctivitis (vkc) in children from 4 years of age and adolescents.